The ESGO-ESTRO-ESP endometrial cancer guidelines working group met again last week after #ESGO2024 in Barcelona! 🙏 We are grateful to the participants for their dedication and hard work!
The group chairs are Nicole Concin (ESGO), Remi Nout (ESTRO), Xavier Matias-Guiu (ESP)
The ESGO representatives are: Nadeem Abu-Rustum, David Cibula, Nicoletta Colombo, Anna Fagotti, Antonio Martín-González, Jonathan Ledermann, Domenica Lorusso, Mansoor Mirza, Ana Oaknin, Jalid Sehouli, Ignace Vergote, Anneke Westermann & Pauline Wimberger
The ESTRO representatives are: Carmen Creutzberg, Cyrus Chargari, Gabriella Macchia, Alina Sturdy & Alexandra Taylor
The ESP representatives are: Tjalling Bosse, Sigurd Lax & Maria Rosaria Raspollini
In addition we thank ENGAGe member Bar Levy, patient representative; methodologist Francois Planchamp; and young clinicians Richard Schwameis, Sophie Espenel & Sonia Gatius
Learn more about this and other ESGO guidelines projects 👉 https://t.co/6xmoLtrhzq
#gynonc #endometrialcancer
0.93 mg iodide in the 25mg powder of ICG! Agree that this is concern is unfounded but abounds everywhere. Our own pharmacy used to (till we published) email us about the ICG and iodine allergy “concern”. So yes a myth and there ya go
January is Cervical Cancer Awareness Month. In the Best of ESGO 2023 manuscript you can find best evaluated original research submitted to the annual @ESGO_society Congress in Istanbul, including abstracts on #cervicalcancer.
https://t.co/yYQJfC7SFE
@IJGConline
@ESGO_society@ENYGO_official @esgo2023
Honored to present our Mayo Clinic Artificial Intelligence based model for the early detection of endometrial cancer and atypical hyperplasia by transvaginal ultrasound in women with postmenopausal bleeding.